Peripheral blood monocyte-derived chemokine blockade prevents murine transfusion-related acute lung injury (TRALI)

Blood

Volumn 123, Issue 22, 2014, Pages 3496-3503

  McKenzie, Christopher G J ^a,b,c   Kim, Michael ^a,b   Singh, Tarandeep K ^a   Milev, Youli ^a   Freedman, John ^a,d   Semple, John W ^a,b,c,d  

^a Toronto Platelet Immunobiology Group   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c CANADIAN BLOOD SERVICES   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

34.1.2S ANTIBODY; ANTIBODY; CXCL3 CHEMOKINE; GADOLINIUM CHLORIDE; IMMUNOGLOBULIN F(AB') 2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; IN VIVO STUDY; LUNG EDEMA; MALE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN CELL; TRANSFUSION RELATED ACUTE LUNG INJURY;

ACUTE LUNG INJURY; ANIMALS; BLOOD TRANSFUSION; CHEMOKINE CXCL2; CHEMOKINES; DISEASE MODELS, ANIMAL; GADOLINIUM; HYPOTHERMIA; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN FC FRAGMENTS; MALE; MICE; MONOCYTES; NEUTROPHILS; SPLEEN;

EID: 84901711797     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-11-536755     Document Type: Article

References (44)

1. Chapman CE, Stainsby D, Jones H, et al.; Serious Hazards of Transfusion Steering Group. Ten years of hemovigilance reports of transfusion related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion. 2009;49(3):440-452.
2. FDA Center for Biologics Evaluation and Research. Fatalities reported to FDA following blood collection and transfusion, annual summary for fiscal year 2008. http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/ ReportaProblem/TransfusionDonationFatalities/ucm113649.htm. Accessed May 2009.
3. Vlaar AP, Hofstra JJ, Determann RM, et al. The incidence, risk factors, and outcome of transfusion-related acute lung injury in a cohort of cardiac surgery patients: a prospective nested case-control study. Blood. 2011;117(16): 4218-4225.
4. Popovsky MA, Moore SB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion. 1985;25(6): 573-577. (Pubitemid 16174471)
5. Silliman CC. The two-event model of transfusionrelated acute lung injury. Crit Care Med. 2006; 34(5 Suppl):S124-S131. (Pubitemid 43670479)
6. Bux J, Sachs UJ. The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol. 2007;136(6):788-799. (Pubitemid 46348408)
7. Fung YL, Silliman CC. The role of neutrophils in the pathogenesis of transfusion-related acute lung injury. Transfus Med Rev. 2009;23(4):266-283.
8. Reil A, Keller-Stanislawski B, Günay S, Bux J. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang. 2008;95(4):313-317.
9. Jensen S, Jersild C, Grunnet N. Severe transfusion reaction to donor plasma containing HLA antibody. Vox Sang. 1990;59(1):62. (Pubitemid 20227682)
10. Win N, Montgomery J, Sage D, Street M, Duncan J, Lucas G. Recurrent transfusion-related acute lung injury. Transfusion. 2001;41(11):1421-1425. (Pubitemid 33104232)
11. Kopko PM, Marshall CS, MacKenzie MR, Holland PV, Popovsky MA. Transfusion-related acute lung injury: report of a clinical look-back investigation. JAMA. 2002;287(15):1968-1971. (Pubitemid 34309755)
12. Nicolle AL, Chapman CE, Carter V, Wallis JP. Transfusion-related acute lung injury caused by two donors with anti-human leucocyte antigen class II antibodies: a look-back investigation. Transfus Med. 2004;14(3):225-230. (Pubitemid 38821561)
13. Silliman CC, Fung YL, Ball JB, Khan SY. Transfusion-related acute lung injury (TRALI): current concepts and misconceptions. Blood Rev. 2009;23(6):245-255.
14. Shaz BH, Stowell SR, Hillyer CD. Transfusionrelated acute lung injury: from bedside to bench and back. Blood. 2011;117(5):1463-1471.
15. Seeger W, Schneider U, Kreusler B, et al. Reproduction of transfusion-related acute lung injury in an ex vivo lung model. Blood. 1990;76(7): 1438-1444. (Pubitemid 20342763)
16. Sachs UJ, Hattar K, Weissmann N, et al. Antibody-induced neutrophil activation as a trigger for transfusion-related acute lung injury in an ex vivo rat lung model. Blood. 2006;107(3): 1217-1219. (Pubitemid 43156327)
17. Silliman CC, Voelkel NF, Allard JD, et al. Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model. J Clin Invest. 1998;101(7):1458-1467. (Pubitemid 28166844)
18. Silliman CC, Bjornsen AJ, Wyman TH, et al. Plasma and lipids from stored platelets cause acute lung injury in an animal model. Transfusion. 2003;43(5):633-640. (Pubitemid 36506360)
19. Kelher MR, Masuno T, Moore EE, et al. Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat model. Blood. 2009;113(9): 2079-2087.
20. Looney MR, Su X, Van Ziffle JA, Lowell CA, Matthay MA. Neutrophils and their Fc gamma receptors are essential in a mouse model of transfusion-related acute lung injury. J Clin Invest. 2006;116(6):1615-1623.
21. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest. 2009;119(11):3450-3461.
22. Fung YL, Kim M, Tabuchi A, et al. Recipient T lymphocytes modulate the severity of antibodymediated transfusion-related acute lung injury. Blood. 2010;116(16):3073-3079.
23. Caudrillier A, Kessenbrock K, Gilliss BM, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest. 2012;122(7):2661-2671.
24. Caudrillier A, Looney MR. Platelet-neutrophil interactions as a target for prevention and treatment of transfusion-related acute lung injury. Curr Pharm Des. 2012;18(22):3260-3266.
25. Strait RT, Hicks W, Barasa N, et al. MHC class I-specific antibody binding to nonhematopoietic cells drives complement activation to induce transfusion-related acute lung injury in mice. J Exp Med. 2011;208(12):2525- 2544.
26. Ozato K, Hansen TH, Sachs DH. Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J Immunol. 1980; 125(6):2473-2477. (Pubitemid 11204138)
27. Thomas GM, Carbo C, Curtis BR, et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood. 2012;119(26):6335-6343.
28. Semple JW, Kim M, Hou J, et al. Intravenous immunoglobulin prevents murine antibodymediated acute lung injury at the level of neutrophil reactive oxygen species (ROS) production. PLoS ONE. 2012;7(2):e31357.
29. De Filippo K, Henderson RB, Laschinger M, Hogg N. Neutrophil chemokines KC and macrophage-inflammatory protein-2 are newly synthesized by tissue macrophages using distinct TLR signaling pathways. J Immunol. 2008;180(6):4308-4315.
30. Hayashi S, Yatsunami J, Fukuno Y, Kawashima M, Miller EJ. Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice. Lung. 2002;180(6):339-348. (Pubitemid 36859689)
31. Ning Y, Imrich A, Goldsmith CA, Qin G, Kobzik L. Alveolar macrophage cytokine production in response to air particles in vitro: role of endotoxin. J Toxicol Environ Health A. 2000;59(3):165-180. (Pubitemid 30095236)
32. Bhatia M, Zemans RL, Jeyaseelan S. Role of chemokines in the pathogenesis of acute lung injury. Am J Respir Cell Mol Biol. 2012;46(5): 566-572.
33. Greenberger MJ, Strieter RM, Kunkel SL, et al. Neutralization of macrophage inflammatory protein-2 attenuates neutrophil recruitment and bacterial clearance in murine Klebsiella pneumonia. J Infect Dis. 1996;173(1):159-165. (Pubitemid 26006815)
34. Bhatia S, Fei M, Yarlagadda M, et al. Rapid host defense against Aspergillus fumigatus involves alveolar macrophages with a predominance of alternatively activated phenotype. PLoS ONE. 2011;6(1):e15943.
35. Frid MG, Brunetti JA, Burke DL, et al. Hypoxiainduced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage. Am J Pathol. 2006;168(2):659-669. (Pubitemid 43271163)
36. Mizgerd JP, Molina RM, Stearns RC, Brain JD, Warner AE. Gadolinium induces macrophage apoptosis. J Leukoc Biol. 1996;59(2):189-195. (Pubitemid 26098704)
37. Singh B, Pearce JW, Gamage LN, Janardhan K, Caldwell S. Depletion of pulmonary intravascular macrophages inhibits acute lung inflammation. Am J Physiol Lung Cell Mol Physiol. 2004;286(2): L363-L372. (Pubitemid 38129518)
38. Thepen T, Van Rooijen N, Kraal G. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J Exp Med. 1989;170(2):499-509. (Pubitemid 19204277)
39. Farley KS, Wang LF, Razavi HM, et al. Effects of macrophage inducible nitric oxide synthase in murine septic lung injury. Am J Physiol Lung Cell Mol Physiol. 2006;290(6):L1164-L1172. (Pubitemid 43830861)
40. Kishta OA, Goldberg P, Husain SN. Gadolinium chloride attenuates sepsis-induced pulmonary apoptosis and acute lung injury. ISRN Inflamm. 2012:393481.
41. Zhao M, Fernandez LG, Doctor A, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am J Physiol Lung Cell Mol Physiol. 2006;291(5): L1018-L1026. (Pubitemid 44772064)
42. Lee CM, Yeoh GC, Olynyk JK. Differential effects of gadolinium chloride on Kupffer cells in vivo and in vitro. Int J Biochem Cell Biol. 2004;36(3): 481-488. (Pubitemid 37542446)
43. Davoren A, Curtis BR, Shulman IA, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion. 2003; 43(5):641-645. (Pubitemid 36506361)
44. Bayat B, Tjahjono Y, Sydykov A, et al. Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33(11):2538-2548.